Zydus Therapeutics Presents Phase 2b Data at AASLD 2026 Showing Greater Resolution of Steatohepatitis Without Worsening of Fibrosis With Investigational Saroglitazar Compared to Placebo in Adults…
The Quick Take
Resolution of steatohepatitis without worsening of fibrosis was achieved by 39.1% of patients receiving saroglitazar magnesium 4 mg and 32.4% receiving 2 mg, compared with 13.7% receiving placebo, after 52 weeks of treatment in adults with metabolic dysfunction-associated steatohepatitis...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
AGNT says housing market is tough but not broken, points to ‘unmatched’ agent value
Revenue rose to $1.4 billion, but net results swung to a $4.3 million loss
Business
Andersen Expands Product Portfolio to Meet Growing Demand for Customization, Design Consistency and Installation Simplicity
Enhancements introduced across Andersen® 100 Series and 400 Series product lines and accessory offerings provide greater customization, design consistency and…
Business
Capitol Securities Welcomes Joe Malave, CFP® & Katy Carrigan
Vice President, Investments-Managing Director | Optimal Wealth Management SARASOTA, Fla., Nov. 6, 2026 /PRNewswire/ -- Capitol Securities Management is pleased…
Local
Milton Hershey School Breaks Ground at Newly Announced Founders Grove
Residential Development Marks Next Phase for Hershey West End HERSHEY, Pa., Nov. 6, 2026 /PRNewswire/ -- Milton Hershey School (MHS), as steward of MHS Trust…